CAPA Applauds Introduction of Leahy/Cornyn Bill to Restore the America Invents Act and Improve Patent Quality
The “Restoring the America Invents Act” Aims to Reduce Big Pharma’s Manipulation of the Patent System and Strengthen Tools Such as the Inter Partes Review Process to Increase Patent Quality
WASHINGTON D.C. – The Coalition Against Patent Abuse (CAPA) released the following statement after Senator Patrick Leahy (D-VT) and Senator John Cornyn (R-TX) introduced the “Restoring the America Invents Act” to reform the U.S. patent system and strengthen tools used by the U.S. Patent and Trademark Office, such as the inter partes review (IPR) process, to weed out low-quality patents and prevent competition from low-cost alternatives in the marketplace.
“CAPA welcomes the introduction of the Restoring the America Invents Act as a practical solution to reducing patent system abuse that denies access to safe, lower-cost medicines for millions of patients,” stated CAPA Executive Director Matthew Lane. “It’s been ten years since the America Invents Act was passed with the goal to balance the value of innovation with price-reducing competition. Unfortunately, continued patent abuse by many major pharmaceutical companies has tilted this balance away from pro-patient, pro-consumer competition and drug pricing. Now, it is up to Congress to enact meaningful legislation to lower drug costs and make true innovation sustainable for generations to come, and this is a strong step towards that goal. CAPA looks forward to continuing our work with Congress to lower drug costs and improve patent quality.”
The “Restoring the America Invents Act” will reform the Patent Act and strengthen tools such as IPR within the USPTO to improve patent quality. The bill will also increase transparency of the Patent Trial and Appeal Board’s (PTAB) patent review process while ensuring it is free from political influence.